VolitionRx Ltd. (VNRX) Starts Presentation at Annual Marcum MicroCap Conference

VolitionRx Ltd. (OTCQB: VNRX) is a life sciences company focused on developing blood-based diagnostic tests for different types of cancer. VolitionRx’s goal is to make the tests as common and simple to use, for both patients and doctors, as existing diabetic and cholesterol blood tests. The company’s research and development activities are currently centered in Belgium as the company focuses on bringing its diagnostic products to market first in Europe, then in the U.S. and ultimately, worldwide. For more information, visit the company’s website at www.volitionrx.com